Randomized Clinical Trial: 03 (Methylphenidate and Duloxetine)

Trial Profile

Randomized Clinical Trial: 03 (Methylphenidate and Duloxetine)

Phase of Trial: Phase I

Latest Information Update: 22 Oct 2016

At a glance

  • Drugs Duloxetine (Primary) ; Methylphenidate (Primary) ; Cocaine
  • Indications Back pain; Chronic fatigue syndrome; Depressive disorders; Diabetic neuropathies; Fibromyalgia; Generalised anxiety disorder; Major depressive disorder; Musculoskeletal pain; Neuropathic pain; Stress incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2016 Protocol is amended as per change in official study title, study design from pharmacodynamics to efficacy/safety study, primary endpoint, purpose and patient number.
    • 17 Oct 2016 Planned number of patients changed from 16 to 40.
    • 17 Oct 2016 Planned End Date changed from 1 Jan 2018 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top